CORE MOLDING TECHNOLOGIES INC [CMT] Filings

10-Q 1 cmt-20230331.htm 10-Q cmt-20230331

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q


☒			QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2023


☐			TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

for the transition period from ____________ to

Commission File Number 001-12505

CORE MOLDING TECHNOLOGIES, INC.

_______________________________________________________________

(Exact name of registrant as specified in its charter)

Delaware

31-1481870

(State or other jurisdiction

incorporation or organization)

(I.R.S. Employer Identification No.)

800 Manor Park Drive, Columbus, Ohio

43228-0183

(Address of principal executive office)

(Zip Code)

Registrant’s telephone number, including area code (614) 870-5000

N/A

__________________________________________________________

Former name, former address and former fiscal year, if changed since last report.

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ¨

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See definition of “accelerated filer,” “large accelerated filer,” and “smaller reporting company,” in Rule 12b-2 of the Exchange Act.

Large accelerated filer ¨

Accelerated filer ¨

Non-accelerated Filer ☒

Smaller reporting company

☒

Emerging growth company

☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

Indicate by check mark whether the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act. Yes ☐ No ☒

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Name of each exchange on which registered

Trading Symbol

Common Stock, par value $0.01

NYSE American LLC

CMT

As of May 8, 2023, the latest practicable date, 9,108,182 shares of the registrant’s common stock were issued, which includes 693,081 shares of unvested restricted common stock.

Table of Contents


Part I — Financial Information

Item 1. Financial Statements (Unaudited)

Consolidated Statements of Operations			3

Consolidated Statements of Comprehensive Income			4

Consolidated Balance Sheets			5

Consolidated Statement of Stockholders’ Equity			6

Consolidated Statements of Cash Flows			7

Notes to Consolidated Financial Statements			8

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations			24

Item 3. Quantitative and Qualitative Disclosures About Market Risk			30

Item 4. Controls and Procedures			30

Part II — Other Information

Item 1. Legal Proceedings			31

Item 1A. Risk Factors			31

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds			31

Item 3. Defaults Upon Senior Securities			31

Item 4. Mine Safety Disclosures			31

Item 5. Other Information			31

Item 6. Exhibits			31

Signatures			32

Index to Exhibits			33

Table of Contents

Part I — Financial Information

Item 1. Financial Statements

Core Molding Technologies, Inc. and Subsidiaries

Consolidated Statements of Operations

(In thousands, except for per share data)

(Unaudited)


	Three months ended March 31,
	2023		2022
Net sales	$	99,507	$	90,592

Cost of sales	81,764		76,085

Gross margin	17,743		14,507

Selling, general and administrative expense	9,668		8,495

Operating income	8,075		6,012

Other income and expense

Interest expense	356		541
Net periodic post-retirement benefit	(52)		(31)
Total other expense	304		510

Income before taxes	7,771		5,502

Income tax expense	1,919		1,638

Net income	$	5,852	$	3,864

Net income per common share:
Basic	$	0.69	$	0.46
Diluted	$	0.66	$	0.46

See notes to unaudited consolidated financial statements.

Table of Contents

Core Molding Technologies, Inc. and Subsidiaries

Consolidated Statements of Comprehensive Income

(In thousands)

(Unaudited)


	Three months ended March 31,
	2023		2022
Net income	$	5,852	$	3,864

Other comprehensive income:

Foreign currency hedging derivatives:
Unrealized hedge gain	488		—
Income tax expense	(105)		—

Interest rate swaps:
Unrealized hedge loss	(306)		—
Income tax benefit	64		—

Post-retirement benefit plan adjustments:
Amortization of net actuarial loss	6		43
Amortization of prior service credits	(124)		(124)
Income tax benefit	25		17

Comprehensive income	$	5,900	$	3,800

See notes to unaudited consolidated financial statements.

Table of Contents

Core Molding Technologies, Inc. and Subsidiaries

Consolidated Balance Sheets

(In thousands, except for share data)


	March 31, 2023		December 31, 2022
	(Unaudited)
Assets:
Current assets:
Cash and cash equivalents	$	4,492	$	4,183
Accounts receivable, net	52,501		44,261
Inventories, net	25,010		23,871
Foreign tax receivable	3,130		2,680
Prepaid expenses and other current assets	6,039		5,670
Total current assets	91,172		80,665

Right of use asset	5,037		5,114
Property, plant and equipment, net	81,730		83,267

Goodwill	17,376		17,376
Intangibles, net	7,207		7,619
Other non-current assets	4,259		4,574
Total Assets	$	206,781	$	198,615

Liabilities and Stockholders’ Equity:
Current liabilities:
Current portion of long-term debt	$	1,205	$	1,208
Revolving debt	—		1,864
Accounts payable	33,244		29,586

Contract liability	3,146		1,395

Compensation and related benefits	7,360		9,101
Accrued other liabilities	8,284		7,643
Total current liabilities	53,239		50,797

Other non-current liabilities	3,027		3,516
Long-term debt	22,685		22,986
Post-retirement benefits liability	5,097		5,191
Total Liabilities	84,048		82,490
Commitments and Contingencies	—		—
Stockholders’ Equity:
Preferred stock — $0.01 par value, authorized shares — 10,000,000; no shares outstanding at March 31, 2023 and December 31, 2022	—		—
Common stock — $0.01 par value, authorized shares – 20,000,000; outstanding shares: 8,420,340 at March 31, 2023 and 8,417,656 at December 31, 2022	84		84
Paid-in capital	41,073		40,342
Accumulated other comprehensive income, net of income taxes	3,101		3,053
Treasury stock - at cost, 3,867,769 shares at March 31, 2023 and 3,866,451 shares at December 31, 2022	(29,122)		(29,099)
Retained earnings	107,597		101,745
Total Stockholders’ Equity	122,733		116,125
Total Liabilities and Stockholders’ Equity	$	206,781	$	198,615

See notes to unaudited consolidated financial statements.

Table of Contents

Core Molding Technologies, Inc. and Subsidiaries

Consolidated Statement of Stockholders’ Equity

(In thousands, except for share data)

(Unaudited)

For the three months ended March 31, 2022:


	Common Stock Outstanding			Paid-In Capital		Accumulated Other Comprehensive Income		Treasury Stock		Retained Earnings		Total Stockholders' Equity
	Shares	Amount
Balance at December 31, 2021	8,235,740	$	82	$	38,013	$	1,075	$	(28,617)	$	89,542	$	100,095
Net income										3,864		3,864
Change in post-retirement benefits, net of tax $17						(64)						(64)

Restricted stock vested	34,422	1										1
Share-based compensation				501								501
Balance at March 31, 2022	8,270,162	$	83	$	38,514	$	1,011	$	(28,617)	$	93,406	$	104,397

For the three months ended March 31, 2023:


	Common Stock Outstanding			Paid-In Capital		Accumulated Other Comprehensive Income		Treasury Stock		Retained Earnings		Total Stockholders' Equity
	Shares	Amount
Balance at December 31, 2022	8,417,656	$	84	$	40,342	$	3,053	$	(29,099)	$	101,745	$	116,125
Net income										5,852		5,852
Change in post-retirement benefits, net of tax of $25						(93)						(93)
Change in foreign currency hedge, net of tax of $105						383						383
Change in interest rate swaps, net of tax of $64						(242)						(242)
Repurchase of common stock	(1,318)	—						(23)				(23)
Issuance of common stock	4,002	—		—								—
Share-based compensation				731								731
Balance at March 31, 2023	8,420,340	$	84	$	41,073	$	3,101	$	(29,122)	$	107,597	$	122,733

See notes to unaudited consolidated financial statements.

Table of Contents

Core Molding Technologies, Inc. and Subsidiaries

Consolidated Statements of Cash Flows

(In thousands)

(Unaudited)


	Three months ended March 31,
	2023		2022
Cash flows from operating activities:
Net income	$	5,852	$	3,864
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
Depreciation and amortization	3,410		3,125
Loss on disposal of property, plant and equipment	80		—

Share-based compensation	731		501

Losses on foreign currency remeasurement	81		240
Change in operating assets and liabilities:
Accounts receivable	(8,240)		(17,031)
Inventories	(1,139)		(3,270)
Prepaid and other assets	(450)		1,502
Accounts payable	4,209		10,407
Accrued and other liabilities	324		(948)
Post-retirement benefits liability	(211)		(47)
Net cash provided by (used in) operating activities	4,647		(1,657)

Cash flows from investing activities:
Purchase of property, plant and equipment	(2,127)		(2,482)
Net cash used in investing activities	(2,127)		(2,482)

Cash flows from financing activities:
Gross repayments on revolving line of credit	(35,369)		(37,444)
Gross borrowings on revolving line of credit	33,505		37,855
Payments related to the purchase of treasury stock	(23)		—


Payment of principal on term loans	(324)		(1,092)
Net cash used in financing activities	(2,211)		(681)

Net change in cash and cash equivalents	309		(4,820)

Cash and cash equivalents at beginning of period	4,183		6,146

Cash and cash equivalents at end of period	$	4,492	$	1,326

Cash paid for:
Interest	$	345	$	420
Income taxes	$	1,931	$	2,198
Non-cash investing activities:
Fixed asset purchases in accounts payable	$	262	$	513

See notes to unaudited consolidated financial statements.

Table of Contents

Core Molding Technologies, Inc. and Subsidiaries

Notes to Consolidated Financial Statements

(Unaudited)

1. BASIS OF PRESENTATION

The accompanying unaudited consolidated financial statements have been prepared in accordance with the instructions to Form 10-Q and include all of the information and disclosures required by accounting principles generally accepted in the United States of America for interim reporting, which are less than those required for annual reporting. In the opinion of management, the accompanying unaudited consolidated financial statements contain all adjustments (all of which are normal and recurring in nature) necessary to present fairly the financial position of Core Molding Technologies, Inc. and its subsidiaries (“Core Molding Technologies” or the “Company”) at March 31, 2023, and the results of operations and cash flows for the three months ended March 31, 2023. The “Notes to Consolidated Financial Statements” contained in the Company's Annual Report on Form 10-K for the year ended December 31, 2022, should be read in conjunction with these consolidated financial statements.

Core Molding Technologies and its subsidiaries operate in the engineered materials market as one operating segment as a molder of thermoplastic and thermoset structural products. The Company produces and sells molded products for varied markets, including medium and heavy-duty trucks, power sports, building products, industrial and utilities and other commercial markets. Core Molding Technologies has its headquarters in Columbus, Ohio, and operates six production facilities in the United States, Canada and Mexico.

2. CRITICAL ACCOUNTING POLICIES AND ESTIMATES

Principles of Consolidation: Management believes the following critical accounting policies, among others, affect its more significant judgments and estimates used in the preparation of its consolidated financial statements.

Use of Estimates: The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosures of contingent assets and liabilities, and reported amounts of revenues and expenses during the reporting period. On an on-going basis, management evaluates its estimates and judgments. Management bases its estimates and judgments on historical experience and on various other factors that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions and conditions.

Revenue Recognition: The Company historically has recognized revenue from two streams, product revenue and tooling revenue. Product revenue is earned from the manufacture and sale of sheet molding compounds and thermoset and thermoplastic products. Revenue from product sales is generally recognized when products are shipped, as the Company transfers control to the customer and is entitled to payment upon shipment. In certain circumstances, the Company recognizes revenue from product sales when products are produced and the customer takes control at our production facility.

Tooling revenue is earned from manufacturing multiple tools, molds and assembly equipment as part of a tooling program for a customer. Given that the Company is providing a significant service of producing highly interdependent component parts of the tooling program, each tooling program consists of a single performance obligation to provide the customer the capability to produce a single product. Based on the arrangement with the customer, the Company recognizes revenue either at a point in time or over a given period. When the Company does not have an enforceable right to payment, the Company recognizes tooling revenue at a point in time. In such cases, the Company recognizes revenue upon customer acceptance, which is when the customer has legal title to the tools.

Certain tooling programs include an enforceable right to payment. In those cases, the Company recognizes revenue over time based on the extent of progress towards completion of its performance obligation. The Company uses a cost-to-cost measure of progress for such contracts because it best depicts the transfer of value to the customer and also correlates with the amount of consideration to which the entity expects to be titled in exchange for transferring the promised goods or services to the customer. Under the cost-to-cost measure of progress, progress towards completion is measured based on the ratio of costs incurred to date to the total estimated costs at completion of the performance obligation. Revenues are recorded proportionally as costs are incurred.

Cash and Cash Equivalents: The Company considers all highly liquid investments purchased with an original maturity of three months or less to be cash equivalents. Cash is held primarily in three banks in three separate jurisdictions. The Company had $4,492,000 cash on hand at March 31, 2023 and had $4,183,000 cash on hand at December 31, 2022.

Table of Contents

Accounts Receivable Allowances: Management maintains allowances for doubtful accounts for estimated losses resulting from the inability of its customers to make required payments. If the financial condition of the Company’s customers were to deteriorate, resulting in an impairment of their ability to make payments, additional allowances may be required. The Company has determined that a $10,000 allowance for doubtful accounts is needed at March 31, 2023 and none at December 31, 2022. Management also records estimates for customer returns and deductions, discounts offered to customers, and for price adjustments. Should customer returns and deductions, discounts, and price adjustments fluctuate from the estimated amounts, additional allowances may be required. The Company had an allowance for estimated chargebacks of $344,000 at March 31, 2023 and $502,000 at December 31, 2022. There have been no material changes in the methodology of these calculations.

Inventories: Inventories, which include material, labor and manufacturing overhead, are valued at the lower of cost or net realizable value. The inventories are accounted for using the first-in, first-out (FIFO) method of determining inventory costs. Inventory quantities on-hand are regularly reviewed, and where necessary, provisions for excess and obsolete inventory are recorded based on historical and anticipated usage. The Company has recorded an allowance for slow moving and obsolete inventory of $536,000 at March 31, 2023 and $433,000 at December 31, 2022.

Contract Assets/Liabilities: Contract assets and liabilities represent the net cumulative customer billings, vendor payments and revenue recognized for tooling programs. For tooling programs where net revenue recognized and vendor payments exceed customer billings, the Company recognizes a contract asset. For tooling programs where net customer billings exceed revenue recognized and vendor payments, the Company recognizes a contract liability. Customer payment terms vary by contract and can range from progress payments based on work performed or one single payment once the contract is completed. The Company has recorded contract assets of $782,000 at March 31, 2023, and $344,000 at December 31, 2022. Contract assets are generally classified as current within prepaid expenses and other current assets on the Consolidated Balance Sheets. For the three months ended March 31, 2023, the Company recognized no impairments on contract assets. For the three months ended March 31, 2023, the Company recognized $622,000 of revenue from contract liabilities related to open jobs outstanding as of December 31, 2022.

Income Taxes: The Company evaluates the balance of deferred tax assets that will be realized based on the premise that the Company is more-likely-than-not to realize deferred tax benefits through the generation of future taxable income.

Long-Lived Assets: Long-lived assets consist primarily of property, plant and equipment and definite-lived intangibles. The recoverability of long-lived assets is evaluated by an analysis of operating results and consideration of other significant events or changes in the business environment. The Company evaluates whether impairment exists for property, plant and equipment on the basis of undiscounted expected future cash flows from operations before interest. There were no impairment charges of the Company’s long-lived assets for the three months ended March 31, 2023 and March 31, 2022, respectively.

Goodwill: The purchase consideration of acquired businesses has been allocated to the assets and liabilities acquired based on the estimated fair values on the respective acquisition dates. Based on these values, the excess purchase consideration over the fair value of the net assets acquired was allocated to goodwill. The Company accounts for goodwill in accordance with FASB ASC Topic 350, Intangibles - Goodwill and Other. FASB ASC Topic 350 prohibits the amortization of goodwill and requires these assets be reviewed for impairment.

The annual impairment tests of goodwill may be completed through qualitative assessments; however, the Company may elect to bypass the qualitative assessment and proceed directly to a quantitative impairment test for any period. The Company may resume the qualitative assessment in any subsequent period.

Under a qualitative and quantitative approach, the impairment test for goodwill consists of an assessment of whether it is more-likely-than-not that the fair value is less than its carrying amount. As part of the qualitative assessment, the Company considers relevant events and circumstances that affect the fair value or carrying amount of the Company. Such events and circumstances could include changes in economic conditions, industry and market conditions, cost factors, overall financial performance, and capital markets pricing. The Company places more weight on the events and circumstances that most affect the Company's fair value or carrying amount. These factors are all considered by management in reaching its conclusion about whether to perform step one of the impairment test. If the Company elects to bypass the qualitative assessment, or if a qualitative assessment indicates it is more-likely-than-not that the estimated carrying value exceeds its fair value, the Company proceeds to a quantitative approach. There were no impairment charges of the Company's goodwill for the three months ended March 31, 2023 and March 31, 2022, respectively.

Self-Insurance: The Company is self-insured with respect to its facilities in Columbus, Ohio; Gaffney, South Carolina; Winona, Minnesota; and Brownsville, Texas for medical, dental and vision claims and Columbus, Ohio for workers’ compensation claims, all of which are subject to stop-loss insurance thresholds. The Company is also self-insured for dental and

Table of Contents

vision with respect to its Cobourg, Canada location. The Company has recorded an estimated liability for self-insured medical, dental and vision claims incurred but not reported and worker’s compensation claims incurred but not reported at March 31, 2023 and December 31, 2022 of $918,000 and $889,000, respectively.

Post-Retirement Benefits: Management records an accrual for post-retirement costs associated with the health care plan sponsored by Core Molding Technologies. Should actual results differ from the assumptions used to determine the reserves, additional provisions may be required. In particular, increases in future healthcare costs above the assumptions could have an adverse effect on Core Molding Technologies’ operations. The effect of a change in healthcare costs is described in Note 12, "Post Retirement Benefits", of the Notes to Consolidated Financial Statements contained in the Company's Annual Report on Form 10-K for the year ended December 31, 2022. Core Molding Technologies had a liability for post-retirement healthcare benefits based on actuarial computed estimates of $6,531,000 at March 31, 2023 and $6,625,000 at December 31, 2022.

3. RECENT ACCOUNTING PRONOUNCEMENTS

Current Expected Credit Loss (CECL)

In June 2016, the FASB issued ASU 2016-13, “Financial Instruments - Credit Losses,” which changes the impairment model for most financial assets and certain other instruments. For trade and other receivables, held-to-maturity debt securities, loans and other instruments, entities will be required to use a new forward-looking “expected loss” model which replaced the previous “incurred loss” model and generally will result in the earlier recognition of allowances for losses. Subsequent to issuing ASU 2016-13, the FASB issued ASU 2018-19, “Codification Improvements to Topic 326, Financial Instruments - Credit Losses,” for the purpose of clarifying certain aspects of ASU 2016-13. ASU 2018-19 has the same effective date and transition requirements as ASU 2016-13. In April 2019, the FASB issued ASU 2019-04, “Codification Improvements to Topic 326, Financial Instruments - Credit Losses, Topic 815, Derivatives and Hedging, and Topic 825, Financial Instruments,” which is effective with the adoption of ASU 2016-13. In May 2019, the FASB issued ASU 2019-05, “Financial Instruments - Credit Losses (Topic 326),” which is also effective with the adoption of ASU 2016-13. In November 2019, the FASB voted to delay the implementation date for certain companies, including those that qualify as a smaller reporting company under the U.S. Securities and Exchange Commission rules, until fiscal years beginning after December 15, 2022. We have adopted this ASU as of January 1, 2023 with no material impact on our consolidated financial position, results of operations, cash flows, or presentation thereof.

Table of Contents

4. NET INCOME PER COMMON SHARE

Net income per common share is computed based on the weighted average number of common shares outstanding during the period. Diluted net income per common share is computed similarly but includes the effect of the assumed exercise of dilutive stock appreciation rights and restricted stock under the treasury stock method.

On May 13, 2021, the Company's stockholders approved the 2021 Long Term Equity Incentive Plan (the “2021 Plan”) that replaced the 2006 Long Term Equity Incentive Plan (the “2006 Plan”) approved in May 2006 and amended in May 2015. The 2021 Plan provides restricted stock award recipients voting rights equivalent to the Company's common stock and accrual of dividends but not receipt of dividends until all conditions or restrictions related to such award have been satisfied. Accordingly, the restricted shares are not considered participating shares. The 2006 Plan provides restricted stock award recipients voting rights equivalent to the Company’s common stock and accrual and receipt of dividends irrespective of any conditions or restrictions related to such award being satisfied. Accordingly, the restricted shares granted from the 2006 Plan are considered a participating security and the Company is required to apply the two-class method to consider the impact of the restricted shares on the calculation of basic and diluted earnings per share.

The computation of basic and diluted net income per common share (in thousands, except for per share data) is as follows:


	Three months ended March 31,
	2023		2022
Net income	$	5,852	$	3,864
Less: net income allocated to participating securities	54		97
Net income available to common stockholders	$	5,798	$	3,767

Weighted average common shares outstanding — basic	8,418,000		8,268,000
Effect of weighted average dilutive securities	334,000		—
Weighted average common and potentially issuable common shares outstanding — diluted	8,752,000		8,268,000

Basic net income per common share	$	0.69	$	0.46
Diluted net income per common share	$	0.66	$	0.46

The computation of basic and diluted net income per participating share is as follows (in thousands, except for per share data):


	Three months ended March 31,
	2023		2022
Net income allocated to participating securities	$	54	$	97

Weighted average participating shares outstanding — basic	78,000		213,000
Effect of dilutive securities	—		—
Weighted average common and potentially issuable common shares outstanding — diluted	78,000		213,000

Basic net income per participating share	$	0.69	$	0.46
Diluted net income per participating share	$	0.69	$	0.46

Table of Contents

5. MAJOR CUSTOMERS

The Company had five major customers during the three months ended March 31, 2023, BRP, Inc. ("BRP"), Navistar, Inc. ("Navistar"), PACCAR, Inc. ("PACCAR"), Universal Forest Products, Inc. ("UFP") and Volvo Group North America, LLC ("Volvo"). Major customers are defined as customers whose sales individually consist of more than ten percent of the Company's total sales during any annual or interim reporting period in the current year. The loss of a significant portion of sales to these customers could have a material adverse effect on the Company.

The following table presents sales revenue for the above-mentioned customers for the three months ended March 31, 2023 and 2022 (in thousands):


	Three months ended March 31,
	2023		2022
BRP product sales	$	12,144	$	12,207
BRP tooling sales	581		150
Total BRP sales	12,725		12,357

Navistar product sales	19,262		14,022
Navistar tooling sales	185		11
Total Navistar sales	19,447		14,033

PACCAR product sales	10,200		8,747
PACCAR tooling sales	67		111
Total PACCAR sales	10,267		8,858

UFP product sales	10,774		12,687
UFP tooling sales	—		—
Total UFP sales	10,774		12,687

Volvo product sales	15,609		10,915
Volvo tooling sales	45		87
Total Volvo sales	15,654		11,002

Other product sales	30,348		31,323
Other tooling sales	292		332
Total other sales	30,640		31,655

Total product sales	98,337		89,901
Total tooling sales	1,170		691
Total sales	$	99,507	$	90,592

Table of Contents

6. INVENTORY

Inventories, net consisted of the following (in thousands):


	March 31, 2023		December 31, 2022
Raw materials	$	16,933	$	16,523
Work in process	2,484		2,929
Finished goods	5,593		4,419
Total	$	25,010	$	23,871

Inventory quantities on-hand are regularly reviewed, and where necessary, provisions for excess and obsolete inventory are recorded based on historical and anticipated usage.

7. LEASES

The Company has operating leases with fixed payment terms for certain buildings and warehouses. The Company's leases have remaining lease terms of less than one year to four years, some of which include options to extend the lease for five years. Operating leases are included in operating lease right-of-use ("ROU") assets, accrued other liabilities and other non-current liabilities in the Consolidated Balance Sheets. ROU assets represent the Company's right to use an underlying asset for the lease term and lease liabilities represent the Company's obligation to make lease payments arising from the lease.

The Company used the applicable incremental borrowing rate at implementation date to measure lease liabilities and ROU assets. The incremental borrowing rate used by the Company was based on baseline rates and adjusted by the credit spreads commensurate with the Company’s secured borrowing rate. At each reporting period when there is a new lease initiated, the Company will utilize its incremental borrowing rate to perform lease classification tests on lease components and to measure ROU assets and lease liabilities.

The components of lease expense were as follows (in thousands):


	Three months ended March 31,
	2023		2022
Operating lease cost	$	427	$	475
Short-term lease cost	$	470	$	385
Total net lease cost	$	897	$	860

Other supplemental balance sheet information related to leases was as follows (in thousands):


	March 31, 2023		December 31, 2022
Operating lease right of use assets	$	5,037	$	5,114

Current operating lease liabilities(A)	$	1,958	$	1,626
Noncurrent operating lease liabilities(B)	3,027		3,516
Total operating lease liabilities	$	4,985	$	5,142

(A)Current operating lease liabilities are included in accrued other liabilities in the Consolidated Balance Sheets.

(B)Noncurrent operating lease liabilities are included in other non-current liabilities in the Consolidated Balance Sheets.

Table of Contents

The following table presents certain information related to lease terms and discount rates for leases:


Operating leases	March 31, 2023		December 31, 2022
Weighted average remaining lease term (in years):	3.0		3.6

Weighted average discount rate:	5.5	%	4.1	%

For the three months ended March 31, 2023 and 2022, cash payments on amounts included in the measurement of lease liabilities were $568,000 and $475,000, respectively. During the three months ended March 31, 2023, the Company terminated a lease for the secondary warehouse in Monterrey, Mexico. As a result, the Company wrote off approximately $1,548,000 and $1,660,000 of lease assets and lease liabilities, respectively, related to this lease. The Company then entered into a new lease related to the secondary warehouse in Monterrey, Mexico, which resulted in right of use assets obtained in exchange for new operating lease liabilities of $641,000 at March 31, 2023. The Company also entered into a new lease related to a warehouse in Matamoros, Mexico, which resulted in additional right of use assets obtained in exchange for new operating lease liabilities of $1,172,000 at March 31, 2023. At March 31, 2022, there were no right of use assets obtained in exchange for new operating lease liabilities.

Maturities of operating lease liabilities were as follows (in thousands):


	March 31, 2023		December 31, 2022
2023 (remainder of year)	$	1,573	$	1,716
2024	2,102		1,722
2025	1,129		1,065
2026	599		979
2027	189		189
Total lease payments	5,592		5,671
Less: imputed interest	(607)		(529)
Total lease obligations	4,985		5,142
Less: current obligations	(1,958)		(1,626)
Long-term lease obligations	$	3,027	$	3,516

8. PROPERTY, PLANT & EQUIPMENT

Property, plant and equipment, net consisted of the following for the periods specified (in thousands):


	March 31, 2023		December 31, 2022
Property, plant and equipment	$	202,046	$	200,525
Accumulated depreciation	(120,316)		(117,258)
Property, plant and equipment — net	$	81,730	$	83,267

Property, plant, and equipment are recorded at cost, unless obtained through acquisition, then assets are recorded at estimated fair value at the date of acquisition. Depreciation is provided on a straight-line method over the estimated useful lives of the assets. The carrying amount of long-lived assets is evaluated annually to determine if an adjustment to the depreciation period or to the unamortized balance is warranted. Depreciation expense for the three months ended March 31, 2023 and 2022 was $2,978,000 and $2,517,000, respectively. Amounts invested in capital additions in progress were $6,508,000 and $7,396,000 at March 31, 2023 and December 31, 2022, respectively. At March 31, 2023 and December 31, 2022, purchase commitments for capital expenditures in progress were $1,498,000 and $2,812,000, respectively.

Table of Contents

9. GOODWILL AND INTANGIBLES

Goodwill activity for the three months ended March 31, 2023 consisted of the following (in thousands):


Balance at December 31, 2022	$	17,376
Additions	—
Impairment	—
Balance at March 31, 2023	$	17,376

Intangibles, net at March 31, 2023 were comprised of the following (in thousands):


Definite-lived Intangible Assets	Amortization Period	Gross Carrying Amount		Accumulated Amortization		Net Carrying Amount
Trade name	25 Years	$	250	$	(80)	$	170
Trademarks	10 Years	1,610		(839)		771
Non-competition agreement	5 Years	1,810		(1,810)		—
Developed technology	7 Years	4,420		(3,288)		1,132
Customer relationships	10-12 Years	9,330		(4,196)		5,134
Total		$	17,420	$	(10,213)	$	7,207

Intangibles, net at December 31, 2022 were comprised of the following (in thousands):


Definite-lived Intangible Assets	Amortization Period	Gross Carrying Amount		Accumulated Amortization		Net Carrying Amount
Trade name	25 Years	$	250	$	(78)	$	172
Trademarks	10 Years	1,610		(798)		812
Non-competition agreement	5 Years	1,810		(1,795)		15
Developed technology	7 Years	4,420		(3,131)		1,289
Customer relationships	10-12 Years	9,330		(3,999)		5,331
Total		$	17,420	$	(9,801)	$	7,619

The aggregate intangible asset amortization expense was $412,000 and $487,000 for the three months ended March 31, 2023 and 2022, respectively.

10. POST-RETIREMENT BENEFITS

The components of expense for the Company’s post-retirement benefit plans are as follows (in thousands):


	Three months ended March 31,
	2023		2022
Pension expense:
Multi-employer plan	$	238	$	207
Defined contribution plan	528		365
Total pension expense	766		572
Health and life insurance:
Interest cost	66		50
Amortization of prior service credits	(124)		(124)
Amortization of net loss	6		43
Net periodic benefit credit	(52)		(31)
Total post-retirement benefits expense	$	714	$	541

Table of Contents

The Company made payments of $624,000 to pension plans and $149,000 for post-retirement healthcare and life insurance during the three months ended March 31, 2023. For the remainder of 2023, the Company expects to make approximately $2,425,000 of pension plan payments, of which $774,000 was accrued at March 31, 2023. The Company also expects to make approximately $1,285,000 of post-retirement healthcare and life insurance payments for the remainder of 2023, all of which were accrued at March 31, 2023.

11. DEBT

Debt consists of the following (in thousands):


	March 31, 2023		December 31, 2022

Huntington term loans payable	24,167		24,479
Leaf Capital term loan payable	76		85
Total	24,243		24,564
Less deferred loan costs	(353)		(370)
Less current portion	(1,205)		(1,208)
Long-term debt	$	22,685	$	22,986

Huntington Credit Agreement

On July 22, 2022, the Company entered into a credit agreement (the “Huntington Credit Agreement”) with The Huntington National Bank (“Huntington”), as the sole lender, administrative agent, lead arranger and book runner, and the lenders from time to time thereto. Pursuant to the terms of the Huntington Credit Agreement, Huntington made available to the Company secured loans (the “Huntington Loans”) in the maximum aggregate principal amount of $75,000,000 ($38,689,000 of which was advanced to the Company on July 22, 2022), comprised of three $25,000,000 commitments: a term loan commitment, a CapEx loan commitment and a revolving loan commitment.

The initial proceeds from the Huntington Credit Agreement were used in part to (i) repay all existing outstanding indebtedness of the Company owing to Wells Fargo Bank, National Association, and FGI Equipment Finance LLC (“FGI”) and (ii) pay certain fees and expenses associated with entering the Huntington Credit Agreement.

At the option of the Company, the Huntington Loans shall be comprised of Alternative Base Rate (ABR) Loans or Secure Overnight Financing Rate (SOFR) Loans.

ABR Loans bear interest at a per annum rate equal to ABR plus a margin of 280 to 330 basis points determined based on the Company’s leverage ratio. ABR is the greatest of (a) the Prime Rate in effect on such day, (b) the Federal Funds Rate in effect on such day plus 0.50% per annum and (c) Daily Simple SOFR for such day (taking into account any floor set forth in the definition of “Daily Simple SOFR”) plus 1.00% per annum; provided, that if the ABR shall be less than 0.00%, then ABR shall be deemed to be 0.00%.

SOFR Loans bear interest at a per annum rate equal to Daily Simple SOFR plus a margin of 180 to 230 basis points determined based on the Company’s leverage ratio. Daily Simple SOFR means, for any day (a “SOFR Rate Day”), a rate per annum equal to the greater of (a) SOFR for the day (such day, the “SOFR Determination Date”) that is five (5) U.S. Government Securities Business Days prior to (i) if such SOFR Rate Day is a U.S. Government Securities Business Day, such SOFR Rate Day or (ii) if such SOFR Rate Day is not a U.S. Government Securities Business Day, the U.S. Government Securities Business Day immediately preceding such SOFR Rate Day, in each case, as such SOFR is published by the SOFR Administrator on the SOFR Administrator’s Website, and (b) 0.00%.

The Company’s obligations under the Huntington Credit Agreement are secured by all of the U.S. and Canadian assets of the Company, including all of its equity interests in each of the Company’s U.S. and Canadian subsidiaries and 65% of the Company’s equity interest in its Mexican subsidiaries, and are unconditionally guaranteed by certain subsidiaries of the Company.

The Huntington Credit Agreement contains certain customary representations and warranties, conditions, affirmative and negative covenants and events of default. The Company is in compliance with such covenants as of March 31, 2023.

Voluntary prepayments of amounts outstanding under the Huntington Loans are permitted at any time without premium or penalty.

Table of Contents

The Company incurred debt origination fees of $402,000 related to the Huntington Credit Agreement, which is being amortized over the life of the agreement.

Huntington Term Loan

Pursuant to the terms of the Huntington Credit Agreement, Huntington made available to the Company a Term Loan commitment (the “Huntington Term Loan”) of $25,000,000 ($25,000,000 of which was advanced to the Company on July 22, 2022). The Huntington Term Loan is to be repaid in monthly installments beginning August 2022 of $104,000 per month for the first 24 months, $156,000 per month for the next 24 months, $208,000 for the next 12 months and the remaining balance to be paid on July 22, 2027.

Interest Rate Swap Agreement

The Company entered into an interest rate swap agreement that became effective July 22, 2022 and continues through July 2027, which was designed as a cash flow hedge for $25,000,000 of the Huntington Term Loan. Under this agreement, the Company will pay a fixed rate of 2.95% to the swap counterparty in exchange for the Term Loans daily variable SOFR. As a result the interest rate paid on the Huntington Term Loan was 4.75% as of March 31, 2023 and December 31, 2022. The fair value of the interest rate swap was an asset of $458,000 and $765,000 at March 31, 2023 and December 31, 2022, respectively.

Huntington Capex Loan

Pursuant to the terms of the Huntington Credit Agreement, Huntington made available to the Company secured Capex loan (the “Huntington Capex Loan”) in the maximum aggregate principal amount of $25,000,000 (none of which was advanced to the Company on July 22, 2022 and through March 31, 2023). Proceeds of the Huntington Capex Loan will be used to finance the ongoing capital expenditure needs of the Company.

Any borrowings from the Huntington Capex Loan will be converted to new term loans annually each February, beginning February 2025, and will have monthly principal repayments based on a sixty-month amortization period with all amounts outstanding on the Huntington Capex Loan being fully due on July 22, 2027.

Huntington Revolving Loan

Pursuant to the terms of the Huntington Credit Agreement, Huntington made available to the Company a revolving loan commitment (the “Huntington Revolving Loan”) of $25,000,000 ($13,689,000 of which was advanced to the Company on July 22, 2022). The Company has $25,000,000 of available revolving loans of which none and $1,864,000 was outstanding as of March 31, 2023 and December 31, 2022, respectively.

The Huntington Credit Agreement makes available to the Company a revolving commitment in the maximum amount of $25,000,000 at the Company’s option at any time during the five-year period following the closing. The revolving loan commitment terminates, and all outstanding borrowings thereunder must be repaid on July 22, 2027.

The interest rate for the Huntington Revolving Loan was 6.38% and 6.12% as of March 31, 2023 and December 31, 2022, respectively.

Leaf Capital Funding

On April 24, 2020 the Company entered into a finance agreement with Leaf Capital Funding of $175,000 for equipment. The parties agreed to a fixed interest rate of 5.50% and a term of 60 months.

Wells Fargo Loan

On March 31, 2022, the Company had term loans ("the WF Term Loans") and a revolving loan (the "WF Revolving loan") with Wells Fargo Bank, National Association, with balances of $13,392,000 and $4,835,000, respectively. The Company’s term and revolving loans had variable interest rates on March 31, 2022 of 3.78% and 4.50%, respectively. On July 22, 2022, all existing outstanding indebtedness of the Company owed to Wells Fargo Bank, National Association was repaid in full as part of the Huntington Credit Agreement.

FGI Equipment Finance LLC Term Loan

On March 31, 2022, the Company had a term loan (the "FGI Term Loan"), evidenced by a promissory note (the "FGI Note") with FGI, with a balance of $12,077,000. The Company’s term loan had a fixed interest rate of 8.25% at March 31, 2022. On July 22, 2022, all existing outstanding indebtedness of the Company owed to FGI was repaid in full as part of the Huntington Credit Agreement.

Table of Contents

12. INCOME TAXES

The Company evaluates the balance of deferred tax assets that will be realized based on the premise that the Company is more-likely-than-not to realize deferred tax benefits through the generation of future taxable income. Management makes assumptions, judgments, and estimates to determine the deferred tax assets and liabilities. The Company evaluates provisions and deferred tax assets quarterly to determine if adjustments to our valuation allowance are required based on the consideration of all available evidence.

At March 31, 2023, the Company had a net deferred tax asset of $3,462,000 consisting of $163,000, $893,000 and $2,406,000 related to tax positions in Canada, Mexico and the United States, respectively. As of March 31, 2023, the Company had a valuation allowance of $1,154,000, against the deferred tax asset related to local tax positions in the Unites States, due to cumulative losses over the last three years and uncertainty related to the Company's ability to realize the deferred assets. The Company believes that the deferred tax assets associated with the Canadian, Mexican, and federal United States. tax jurisdictions are more-likely-than-not to be realizable based on estimates of future taxable income.

Income tax expense for the three months ended March 31, 2023 is estimated to be $1,919,000, approximately 24.7% of income before income taxes. Income tax expense for the three months ended March 31, 2022 was estimated to be $1,638,000, approximately 29.8% of loss before income taxes.

The Company files income tax returns in the United States, Mexico, Canada and various state and local jurisdictions. The Company is subject to federal income tax examinations for tax years 2014 through 2017 but the scope of examination is limited to adjustments resulting from Net Operating Loss carry back claims from the 2018, 2019, and 2020 tax years. The Company is subject to federal income tax examinations for years 2018 through 2021 with unlimited scope. The Company is not subject to state examinations for years before 2017. The Company is not subject to Mexican income tax examinations by Mexican authorities for the years before 2017 and is not subject to Canadian income tax examinations by Canadian authorities for the years before 2018.

13. STOCK BASED COMPENSATION

On May 13, 2021, The Company's stockholders approved the 2021 Long Term Equity Incentive Plan (the “2021 Plan”) that replaced the 2006 Long Term Equity Incentive Plan (the “2006 Plan”) approved in May 2006 and amended in May 2015. The 2021 Plan allows for grants to employees, officers, non-employee directors, consultants, independent contractors and advisors of non-qualified stock options, incentive stock options, stock appreciation rights, restricted stock, restricted stock units, and other stock-based awards (“stock awards”) up to an aggregate of 250,824 awards. Awards can be granted under the 2021 Plan through the earlier of May 13, 2031, or the date the maximum number of available awards under the 2021 Plan have been granted. No new awards may be granted from the 2006 Plan.

Awards under the 2021 Plan vest over one to three years and shares previously awarded and currently unvested under the 2006 Plan vest over three years. Shares granted under both the 2006 and 2021 Plans vest immediately upon the date of a participant’s death, disability or change in control.

The Company follows the provisions of FASB ASC 718 requiring that compensation cost relating to share-based payment transactions be recognized in the financial statements. The cost is measured at the grant date, based on the calculated fair value of the award, and is recognized as an expense over the employee's requisite service period (generally the vesting period of the equity award).

Restricted Stock

The Company grants shares of its common stock to certain directors, officers, key managers and employees in the form of unvested stock and units (“Restricted Stock”). These awards are measured at the fair value of the Company's common stock on the date of issuance and recognized ratably as compensation expense over the applicable vesting period, which is typically three years. The Company adjusts compensation expense for actual forfeitures, as they occur.

Table of Contents

The following summarizes the status of Restricted Stock and changes during the three months ended March 31, 2023:


	Number of Shares	Weighted Average Grant Date Fair Value
Unvested balance at December 31, 2022	502,747	$	10.46
Granted	179,580	15.98
Vested	—	—
Forfeited	(2,596)	10.40
Unvested balance at March 31, 2023	679,731	$	11.95

At March 31, 2023 and 2022, there was $5,702,000 and $2,579,000, respectively, of total unrecognized compensation expense, related to Restricted Stock grants. The unrecognized compensation expense at March 31, 2023 is expected to be recognized over the weighted-average period of 2.3 years. Total compensation cost related to Restricted Stock grants for the three months ended March 31, 2023 and 2022 was $725,000 and $468,000, respectively, all of which was recorded to selling, general and administrative expense.

During the three months ended March 31, 2023 and March 31, 2022, employees withheld no shares of the Company's common stock to satisfy income tax withholding obligations in connection with the vesting of restricted awards.

Performance Restricted Stock Awards

The Company grants shares of its common stock to certain officers and key managers in the form of shares of performance-based restricted stock ("Performance Restricted Stock Awards"). These awards are measured at the fair value of the Company's common stock on the date of issuance and recognized ratably as compensation expense over the applicable vesting period to the extent that the performance measures have been satisfied as of the last day of the performance period of the award. The total amount payable as of the award's vesting date is determined by the three year average Operational Income and Return on Capital Employed performance measure achievement. The Company adjusts compensation expense for actual forfeitures as they occur, and for estimated performance measure achievement.

The following summarizes the status of Performance Restricted Stock Awards and changes during the three months ended March 31, 2023:


	Number of Shares	Weighted Average Grant Date Fair Value
Unvested balance at December 31, 2022	—	$	—
Granted	13,350	15.98
Vested	—	—
Forfeited	—	—
Unvested balance at March 31, 2023	13,350	$	15.98

At March 31, 2023, there was $207,000 of total unrecognized compensation expense related to Performance Restricted Stock Awards. As of March 31, 2022, there was no unrecognized compensation expense related to Performance Restricted Stock Awards. The unrecognized compensation expense at March 31, 2023 is expected to be recognized over the weighted-average period of 2.9 years. Total compensation cost related to Performance Restricted Stock Awards for the three months ended March 31, 2023 was $6,000, all of which was recorded to selling, general and administrative expense.

Stock Appreciation Rights

As part of the Company's 2019 annual grant, Stock Appreciation Rights ("SARs") were granted with a grant price of $10. These awards have a contractual term of five years and vest ratably over a period of three years or immediately vest if the recipient is over 65 of age. These awards are valued using the Black-Scholes option pricing model, and are recognized ratably as compensation expense over three years.

Table of Contents

A summary of the Company's stock appreciation rights activity for the three months ended March 31, 2023 is as follows:


	Number of Shares	Weighted Average Exercise Price
Outstanding as of December 31, 2022	177,016	$	10.00
Granted	—	—
Exercised	(4,002)	10.00
Forfeited	—	—
Outstanding at end of the period ended March 31, 2023	173,014	$	10.00
Exercisable at end of the period ended March 31, 2023	173,014	$	10.00

At March 31, 2023, the weighted average grant date fair value of outstanding SARs was $2.57. The aggregate intrinsic value of SARs as of March 31, 2023 was $1,382,000. The total intrinsic value of SARs exercised as of March 31, 2023 was $30,000. The average remaining contractual term for SARs outstanding at March 31, 2023 is 1.1 years. There was no unrecognized compensation expense, related to SARs at March 31, 2023. For the three months ended March 31, 2023, there was no compensation cost. Total compensation cost related to SARs for the three months ended March 31, 2022 was $33,000, all of which was recorded to selling, general and administrative expense.

During the three months ended March 31, 2023, employees withheld 1,318 shares of common stock to satisfy income tax withholding obligations in connection with the exercise of stock appreciation rights. Employees withheld no shares for the three months ended March 31, 2022.

14. FAIR VALUE OF FINANCIAL INSTRUMENTS

Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in a transaction between market participants as of the measurement date. Fair value is measured using the fair value hierarchy and related valuation methodologies as defined in the authoritative literature. This hierarchical valuation methodology provides a fair value framework that describes the categorization of assets and liabilities in three levels based upon the assumptions (inputs) used to price the assets or liabilities. Level 1 provides the most reliable measure of fair value, whereas Level 3 generally requires significant management judgment.

The three levels are defined as follows:

Level 1 - Quoted prices in active markets for identical assets and liabilities.

Level 2 - Quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active and model-derived valuations, in which all significant inputs are observable in active markets.

Level 3 -Significant unobservable inputs reflecting management's own assumptions about the inputs used in pricing the asset or liability.

The Company’s financial instruments consist of cash and cash equivalents, accounts receivable, accounts payable, debt, interest rate swaps and foreign currency derivatives. Cash and cash equivalents, accounts receivable and accounts payable carrying values as of March 31, 2023 and December 31, 2022 approximate fair value due to the short-term maturities of these financial instruments. As of March 31, 2023 and December 31, 2022, the carrying amounts of the Huntington Term Loan and Huntington Revolving Loan approximated fair value due to the short-term nature of the underlying variable rate SOFR used to determine interest charged on the loans. The Company had Level 2 fair value measurements at March 31, 2023 relating to the Company’s interest rate swaps and foreign currency derivatives.

Table of Contents

Derivative and hedging activities

Foreign Currency Derivatives

The Company conducted business in foreign countries and paid certain expenses in foreign currencies; therefore, the Company was exposed to foreign currency exchange risk between the U.S. Dollar and foreign currencies, which could impact the Company’s operating income and cash flows. To mitigate risk associated with foreign currency exchange, the Company entered into forward contracts to exchange a fixed amount of U.S. Dollars for a fixed amount of foreign currency, which will be used to fund future foreign currency cash flows. At inception, all forward contracts are formally documented as cash flow hedges and are measured at fair value each reporting period.

Derivatives are formally assessed both at inception and at least quarterly thereafter, to ensure that derivatives used in hedging transactions are highly effective in offsetting changes in cash flows of the hedged item. If it is determined that a derivative ceases to be a highly effective hedge, or if the anticipated transaction is no longer probable of occurring, hedge accounting is discontinued, and any future mark-to-market adjustments are recognized in earnings. The effective portion of gain or loss is reported in other comprehensive income and the ineffective portion is reported in earnings. The impacts of these contracts were largely offset by gains and losses resulting from the impact of changes in exchange rates on transactions denominated in the foreign currency. As of March 31, 2023, the Company had no ineffective portion related to the cash flow hedges.

Interest Rate Swap

The Company entered into an interest rate swap contract to fix the interest rate on an initial aggregate amount of $25,000,000 thereby reducing exposure to interest rate changes. The interest rate swap pays a fixed rate of 2.95% to the swap counterparty in exchange for daily SOFR. At inception, all interest rate swaps were formally documented as cash flow hedges and are measured at fair value each reporting period. See Note 11, "Debt", for additional information.

Financial statement impacts

The following table detail amounts related to our derivatives designated as hedging instruments (in thousands):


	Fair Value of Derivative Instruments March 31, 2023
	Asset Derivatives			Liability Derivatives
	Balance Sheet Location	Fair Value		Balance Sheet Location	Fair Value
Foreign exchange contracts	Prepaid expenses other current assets	$	620	Accrued other liabilities	$	126
	Other non-current assets	$	—	Other non-current liabilities	$	92
Notional contract values		$	21,398		$	7,194

Interest rate swaps	Prepaid expenses other current assets	$	425	Accrued other liabilities	$	—
	Other non-current assets	$	33	Other non-current liabilities	$	—
Notional contract values		$	24,167		$	—

Table of Contents


	Fair Value of Derivative Instruments December 31, 2022
	Asset Derivatives			Liability Derivatives
	Balance Sheet Location	Fair Value		Balance Sheet Location	Fair Value
Foreign exchange contracts	Prepaid expenses other current assets	$	72	Accrued other liabilities	$	157
	Other non-current assets	$	—	Other non-current liabilities	$	—
Notional contract values		$	3,379		$	10,472

Interest rate swaps	Prepaid expenses other current assets	$	280	Accrued other liabilities	$	—
	Other non-current assets	$	485	Other non-current liabilities	$	—
Notional contract values		$	24,479		$	—

The following tables summarize the amount of unrealized and realized gain (loss) recognized in Accumulated Other Comprehensive Income ("AOCI") for the three months ended March 31, 2023 and 2022 (in thousands):


Derivatives in subtopic 815-20 Cash Flow Hedging Relationship:	Amount of Unrealized Gain (Loss) Recognized in Accumulated Other Comprehensive Income on Derivative				Location of Gain (Loss) Reclassified from Accumulated Other Comprehensive Income(A)	Amount of Realized Gain (Loss) Reclassified from Accumulated Other Comprehensive Income
	2023		2022			2023		2022
Foreign exchange contracts	$	620	$	—	Cost of goods sold	$	119	$	—
					Selling, general and administrative expense	$	13	$	—
Interest rate swaps	$	(212)	$	—	Interest expense	$	94	$	—

(A) The foreign currency derivative activity reclassified from Accumulated Other Comprehensive Income is allocated to cost of goods sold and selling, general and administrative expense based on the percentage of foreign currency spend.

Table of Contents

15. ACCUMULATED OTHER COMPREHENSIVE INCOME

The following table presents changes in Accumulated Other Comprehensive Income, net of tax, for the three months ended March 31, 2023 and 2022 (in thousands):


2022:	Derivative Hedging Activities		Post Retirement Benefit Plan Items(A)		Accumulated Other Comprehensive Income (Loss)
2022:
Balance at December 31, 2021	$	—	$	1,075	$	1,075

Amounts reclassified from accumulated other comprehensive income	—		(81)		(81)
Income tax benefit	—		17		17
Balance at March 31, 2022	$	—	$	1,011	$	1,011

2023:
Balance at December 31, 2022	$	546	$	2,507	$	3,053
Other comprehensive income before reclassifications	408		—		408
Amounts reclassified from accumulated other comprehensive income	(226)		(118)		(344)
Income tax benefit (expense)	(41)		25		(16)
Balance at March 31, 2023	$	687	$	2,414	$	3,101

(A)The effect of post-retirement benefit items reclassified from Accumulated Other Comprehensive Income is included in other income and expense on the Consolidated Statements of Operations. These Accumulated Other Comprehensive Income components are included in the computation of net periodic benefit cost (see Note 10, "Post-Retirement Benefits" for additional details). The tax effect of post-retirement benefit items reclassified from Accumulated Other Comprehensive Income is included in income tax expense on the Consolidated Statements of Operations.

Table of Contents

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

This Management's Discussion and Analysis of Financial Condition and Results of Operations contains forward-looking statements within the meaning of the federal securities laws, which are subject to the "safe harbor" created by Section 27A of the Securities Act of 1933, as amended (the "Securities Act"), and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exhcange Act"). As a general matter, forward-looking statements are those focused upon future plans, objectives or performance as opposed to historical items and include statements of anticipated events or trends and expectations and beliefs relating to matters not historical in nature. Such forward-looking statements involve known and unknown risks and are subject to uncertainties and factors relating to Core Molding Technologies' operations and business environment, all of which are difficult to predict and many of which are beyond Core Molding Technologies' control. Words such as “may,” “will,” “could,” “would,” “should,” “anticipate,” “predict,” “potential,” “continue,” “expect,” “intend,” “plans,” “projects,” “believes,” “estimates,” “encouraged,” “confident” and similar expressions are used to identify these forward-looking statements. These uncertainties and factors could cause Core Molding Technologies' actual results to differ materially from those matters expressed in or implied by such forward-looking statements.

Core Molding Technologies believes that the following factors, among others, could affect its future performance and cause actual results to differ materially from those expressed or implied by forward-looking statements made in this Quarterly Report on Form 10-Q: business conditions in the plastics, transportation, power sports, utilities and commercial product industries (including changes in demand for truck production);

•federal and state regulations (including engine emission regulations);

•general macroeconomic conditions, including uncertainties surrounding volatility i